Media Pack
News

Current Edition

Volume 16 Issue 2
 
news

Clinerion Patient Network Explorer technology used by the Swiss Personalized Health Network (SPHN) to enable feasibility queries on clinical data across all five of Switzerland’s university hospitals simultaneously

Clinerion Patient Network Explorer technology powers the Federated Query System (FQS) of the Swiss Personalized Health Network (SPHN), which operates across all fi...
22 November 2021 news Clinerion | Clinerion Patient Network Explorer
Continue Reading →
Asia Pacific

SGS INCREASES BIOSAFETY TESTING CAPACITY AT ITS GLASGOW FACILITY

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...
28 October 2021 Asia Pacific | Australasia | Europe | news | North America | Regional News biosafety | BSL-2 laboratories
Continue Reading →
news

Johnson &Johnson’s COVID-19 shot hit again as feds plan to tag Guillain-Barré warning on label: reports

Johnson & Johnson’s COVID-19 vaccine has encountered numerous setbacks ranging from manufacturing issues to an emergency safety review. Use of the vaccine hasn't...
14 July 2021 news
Continue Reading →
Europe

SGS’s Outstanding Work Recognized by Customers at the CRO Leadership Awards 2021

For the fifth consecutive year, SGS Health Science has been recognized by the exclusive CRO Leadership Awards. In the 2021 awards, SGS was delighted to win three awa...
27 April 2021 Europe | news
Continue Reading →
Europe

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term Ahead of CPhI Discover (17th-28th May 2021) – global pharma’s larg...
26 April 2021 Europe | news
Continue Reading →
Europe

SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical, Inc. (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-...
30 March 2021 Europe | news
Continue Reading →
news

CPhI Worldwide Announces New November 2021 Dates

At CPhI Worldwide, we understand the importance of meeting face-to-face with your peers and potential business partners.  In 2021 we will bring the global pharma comm...
15 January 2021 news | Regional News
Continue Reading →
news

Japan’s Kobayashi Kako admits manufacturing mix-up led to patient’s death

A "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effect...
21 December 2020 news | Regional News
Continue Reading →
news

AbbVie’s Botox wins reprieve as agency bars Evolus’ Jeaveau for alleged trade-secrets theft

AbbVie's aiming to make the most out of its new moneymaker Botox, gained in its Allergan megamerger last year, and it just scored a legal win—against ...
21 December 2020 news | Regional News
Continue Reading →
news

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

MacroGenics’ oncology med Margenza is launching into the crowded HER2-positive breast cancer field. But the company has one advantage it can tout: The drug topped Ro...
21 December 2020 news | Regional News
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte